Waldencast plc

NasdaqCM:WALD

Sector

🏥 Health Care

Industries

🧴 Personal Care

💄 Cosmetics

🦷 Dental Care

💻 Telehealth

Location

United States

Market Cap

USD 308.76 M

Share Price

USD 2.60

Avg Daily Volume

93,966

Change (1 day)

3.59%

Change (1 year)

-33.67%

Change (YTD)

-35.32%

Waldencast plc Receivables for the year ending December 31, 2024: USD 26.28 M

Waldencast plc Receivables is USD 26.28 M for the year ending December 31, 2024, a 17.14% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.

Waldencast plc Receivables for the year ending December 31, 2023 was USD 22.43 M, a 14.77% change year over year.
Waldencast plc Receivables for the year ending December 31, 2022 was USD 19.54 M, a 4.30% change year over year.
Waldencast plc Receivables for the year ending December 31, 2021 was USD 18.74 M.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Receivables	Inventory	Current Assets	Property, Plant, Equipment (Net)

NasdaqCM: WALD

Waldencast plc

CEO	Mr. Michel Brousset
IPO Date	May 12, 2021
Location	United States
Headquarters	10 Bank Street
Employees	335
Sector	🏥 Health Care
Industries Personal Care 💄 Cosmetics 🦷 Dental Care 💻 Telehealth

Description

Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.